Janus Henderson Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $702M | Buy |
|
|||||
2025
Q1 | $764M | Sell |
|
|||||
2024
Q4 | $755M | Sell |
|
|||||
2024
Q3 | $1.98B | Sell |
|
|||||
2024
Q2 | $1.96B | Buy |
|
|||||
2024
Q1 | $1.98B | Buy |
|
|||||
2023
Q4 | $1.5B | Buy |
|
|||||
2023
Q3 | $1.42B | Sell |
|
|||||
2023
Q2 | $1.44B | Sell |
|
|||||
2023
Q1 | $2.15B | Sell |
|
|||||
2022
Q4 | $2.51B | Sell |
|
|||||
2022
Q3 | $4.35B | Buy |
|
|||||
2022
Q2 | $2.49B | Sell |
|
|||||
2022
Q1 | $2.78B | Buy |
|
|||||
2021
Q4 | $2B | Sell |
|
|||||
2021
Q3 | $1.77B | Sell |
|
|||||
2021
Q2 | $2.01B | Sell |
|
|||||
2021
Q1 | $1.99B | Buy |
|
|||||
2020
Q4 | $1.96B | Buy |
|
|||||
2020
Q3 | $1.49B | Buy |
|
|||||
2020
Q2 | $1.61B | Buy |
|
|||||
2020
Q1 | $877M | Buy |
|
|||||
2019
Q4 | $558M | Buy |
|
|||||
2019
Q3 | $284M | Sell |
|
|||||
2019
Q2 | $644M | Sell |
|
|||||
2019
Q1 | $807M | Buy |
|
|||||
2018
Q4 | $841M | Buy |
|
|||||
2018
Q3 | $469M | Sell |
|
|||||
2018
Q2 | $486M | Buy |
|
|||||
2018
Q1 | $428M | Buy |
|
|||||
2017
Q4 | $214M | Buy |
|
|||||
2017
Q3 | $164M | Sell |
|
|||||
2017
Q2 | $278M | Buy |
|
|||||
2017
Q1 | $12.2M | Sell |
|
|||||
2016
Q4 | $11.9M | Sell |
|
|||||
2016
Q3 | $12.1M | Sell |
|
|||||
2016
Q2 | $12.2M | Sell |
|
|||||
2016
Q1 | $12M | Buy |
|
|||||
2015
Q4 | $12.3M | Sell |
|
|||||
2015
Q3 | $12.1M | Buy |
|
|||||
2015
Q2 | $14.6M | Buy |
|
|||||
2015
Q1 | $12.6M | Sell |
|
|||||
2014
Q4 | $14.7M | Hold |
|
|||||
2014
Q3 | $13M | Sell |
|
|||||
2014
Q2 | $13.9M | Buy |
|
|||||
2014
Q1 | $12.2M | Buy |
|
|||||
2013
Q4 | $11.5M | Buy |
|
|||||
2013
Q3 | $9.35M | Sell |
|
|||||
2013
Q2 | $8.73M | Buy |
|